X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs LUPIN LTD - Comparison Results

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE LUPIN LTD SUVEN LIFE/
LUPIN LTD
 
P/E (TTM) x 20.6 23.1 89.4% View Chart
P/BV x 3.8 3.1 122.3% View Chart
Dividend Yield % 1.0 0.8 122.2%  

Financials

 SUVEN LIFE   LUPIN LTD
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
LUPIN LTD
Mar-17
SUVEN LIFE/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs3391,750 19.3%   
Low Rs1441,384 10.4%   
Sales per share (Unadj.) Rs39.2387.4 10.1%  
Earnings per share (Unadj.) Rs7.556.6 13.2%  
Cash flow per share (Unadj.) Rs8.876.8 11.4%  
Dividends per share (Unadj.) Rs2.007.50 26.7%  
Dividend yield (eoy) %0.80.5 173.0%  
Book value per share (Unadj.) Rs49.0298.9 16.4%  
Shares outstanding (eoy) m127.28451.58 28.2%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x6.24.0 152.1%   
Avg P/E ratio x32.427.7 117.0%  
P/CF ratio (eoy) x27.520.4 134.9%  
Price / Book Value ratio x4.95.2 94.0%  
Dividend payout %26.813.2 202.4%   
Avg Mkt Cap Rs m30,732707,513 4.3%   
No. of employees `0001.016.8 5.7%   
Total wages/salary Rs m41628,495 1.5%   
Avg. sales/employee Rs Th5,236.110,418.3 50.3%   
Avg. wages/employee Rs Th436.51,697.0 25.7%   
Avg. net profit/employee Rs Th995.51,523.0 65.4%   
INCOME DATA
Net Sales Rs m4,995174,943 2.9%  
Other income Rs m1941,065 18.2%   
Total revenues Rs m5,189176,008 2.9%   
Gross profit Rs m1,23344,931 2.7%  
Depreciation Rs m1679,122 1.8%   
Interest Rs m541,525 3.6%   
Profit before tax Rs m1,20535,349 3.4%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m083 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2559,785 2.6%   
Profit after tax Rs m95025,575 3.7%  
Gross profit margin %24.725.7 96.1%  
Effective tax rate %21.227.7 76.5%   
Net profit margin %19.014.6 130.1%  
BALANCE SHEET DATA
Current assets Rs m4,986119,542 4.2%   
Current liabilities Rs m1,04261,206 1.7%   
Net working cap to sales %79.033.3 236.8%  
Current ratio x4.82.0 244.9%  
Inventory Days Days6176 80.3%  
Debtors Days Days3990 43.5%  
Net fixed assets Rs m3,126131,660 2.4%   
Share capital Rs m127903 14.1%   
"Free" reserves Rs m3,717134,073 2.8%   
Net worth Rs m6,236134,976 4.6%   
Long term debt Rs m43256,478 0.8%   
Total assets Rs m8,079266,073 3.0%  
Interest coverage x23.224.2 96.1%   
Debt to equity ratio x0.10.4 16.6%  
Sales to assets ratio x0.60.7 94.0%   
Return on assets %12.410.2 122.0%  
Return on equity %15.218.9 80.4%  
Return on capital %18.919.3 98.0%  
Exports to sales %87.50-   
Imports to sales %12.20-   
Exports (fob) Rs m4,371NA-   
Imports (cif) Rs m611NA-   
Fx inflow Rs m4,66681,885 5.7%   
Fx outflow Rs m94221,506 4.4%   
Net fx Rs m3,72460,378 6.2%   
CASH FLOW
From Operations Rs m92241,148 2.2%  
From Investments Rs m-619-25,287 2.4%  
From Financial Activity Rs m-6984,332 -16.1%  
Net Cashflow Rs m-39620,193 -2.0%  

Share Holding

Indian Promoters % 63.4 46.6 136.1%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 0.0 11.3 -  
FIIs % 0.0 31.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 10.1 361.4%  
Shareholders   37,287 98,259 37.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   DR. DATSONS LABS  STRIDES SHASUN LTD  FDC LTD.  JUBILANT LIFE SCIENCES  BIOCON LTD  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Breaches 36,000 Mark; ONGC Nears 52-Week High(Closing)

The NSE Nifty on Tuesday sailed past the 11,000 mark, while the BSE Sensex breached the 36,000 level for the first time after an IMF report showed India was set to regain.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Jan 23, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - NATCO PHARMA COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS